The supplier announced this week that it now the holder of 308 separate patents in jurisdictions across the globe, including in several recent patents granted in Australia, Canada, Europe and the United States. The portfolio includes composition, use and process patents.
The company said its patents cover familiar and successful ingredients such as its LactoSpore Bacillus coagulans probiotic, its Curcumin C3 Complex turmeric extract and its DigeZyme digestive enzyme offering. The company has also secured patents on newer ingredients such as NIgellin an extract of Nigella sativa or ‘black seed,’ which has immune system and liver health benefits, and Sabroxy, extract prepared from the dried bark of the Indian trumpet tree (Oroxylum indicum) that is used for memory support.
BioPerine led the way
Sabinsa, which was founded by Dr Muhammed Majeed in New Jersey the 1990s after a career in the pharmaceutical industry, filed its first patent in 1996 on BioPerine, its black pepper extract. Sabinsa developed the science behind the ingredient’s ability to enhance uptake of active ingredients in the digestive tract. The ingredient has become popular both for its underlying science and for its small inclusion rates. BioPerine has been shown to be effective in doses as small as 5 mg.
Dr Majeed said the company’s extensive IP portfolio, which he said be believes to be the most extensive in the industry, is a differentiator for its customers.
“I think our customer base likes the patents and the science we can develop based on the patents. Many of our customers would prefer to have patent-based science as a support to their marketing of the products,” Dr Majeed told NutraIngredients-USA.